Clearmind Medicine Inc. reported earnings results for the first quarter ended January 31, 2024. For the first quarter, the company reported net loss was USD 1.37 million compared to USD 1.9 million a year ago. Basic loss per share from continuing operations was USD 0.9 compared to USD 24.8 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | -3.33% | -2.11% | -58.72% |
1st Jan change | Capi. | |
---|---|---|
-58.72% | 3.78M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CMND Stock
- News Clearmind Medicine Inc.
- Clearmind Medicine Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024